Published in
Elsevier, Transfusion and Apheresis Science, 1(57), p. 91-96, 2018
DOI: 10.1016/j.transci.2018.01.002
Links
Tools
Lipoprotein apheresis affects lipoprotein particle subclasses more efficiently compared to the PCSK9 inhibitor evolocumab, a pilot study
Journal article published in 2018 by
Knut Tore Lappegård,
Christian Abendstein Kjellmo,
Stefan Ljunggren,
Karin Cederbrant,
Maritha Marcusson-Ståhl,
Monica Mathisen,
Helen Karlsson 
,
Anders Hovland
,
Anders Hovland
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 